343 related articles for article (PubMed ID: 18612271)
21. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.
Dikopoulos N; Riedl P; Schirmbeck R; Reimann J
Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434
[TBL] [Abstract][Full Text] [Related]
22. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection.
Böhm W; Kuhröber A; Paier T; Mertens T; Reimann J; Schirmbeck R
J Immunol Methods; 1996 Jun; 193(1):29-40. PubMed ID: 8690928
[TBL] [Abstract][Full Text] [Related]
23. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
24. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
25. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
27. miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigens.
Kron MW; Espenlaub S; Engler T; Schirmbeck R; Kochanek S; Kreppel F
Mol Ther; 2011 Aug; 19(8):1547-57. PubMed ID: 21556053
[TBL] [Abstract][Full Text] [Related]
28. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
29. HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection.
Loirat D; Mancini-Bourgine M; Abastado JP; Michel ML
Int Immunol; 2003 Oct; 15(10):1125-36. PubMed ID: 13679383
[TBL] [Abstract][Full Text] [Related]
30. The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells.
Henning P; Gustafsson T; Flach CF; Hua YJ; Strömbeck A; Holmgren J; Lindholm L; Yrlid U
Eur J Immunol; 2011 Aug; 41(8):2185-96. PubMed ID: 21538977
[TBL] [Abstract][Full Text] [Related]
31. Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells.
Radcliffe JN; Roddick JS; Friedmann PS; Stevenson FK; Thirdborough SM
J Immunol; 2006 Nov; 177(10):6626-33. PubMed ID: 17082574
[TBL] [Abstract][Full Text] [Related]
32. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.
Rodriguez F; Harkins S; Slifka MK; Whitton JL
J Virol; 2002 May; 76(9):4251-9. PubMed ID: 11932390
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity.
Tenbusch M; Kuate S; Tippler B; Gerlach N; Schimmer S; Dittmer U; Uberla K
BMC Immunol; 2008 Apr; 9():13. PubMed ID: 18405363
[TBL] [Abstract][Full Text] [Related]
34. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
35. Mutating the anchor residues associated with MHC binding inhibits and deviates CD8+ T cell mediated protective immunity against malaria.
Dobaño C; McTague A; Sette A; Hoffman SL; Rogers WO; Doolan DL
Mol Immunol; 2007 Mar; 44(9):2235-48. PubMed ID: 17169429
[TBL] [Abstract][Full Text] [Related]
36. Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.
Hill BJ; Darrah PA; Ende Z; Ambrozak DR; Quinn KM; Darko S; Gostick E; Wooldridge L; van den Berg HA; Venturi V; Larsen M; Davenport MP; Seder RA; Price DA; Douek DC
J Immunol; 2014 Dec; 193(11):5626-36. PubMed ID: 25348625
[TBL] [Abstract][Full Text] [Related]
37. [Construction of eukaryotic expression plasmids inserting HBsAg gene and DNA immunization responses to HBsAg in mice].
Liang Z; Lan Y; Li Y; Cai D; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):106-8. PubMed ID: 11983125
[TBL] [Abstract][Full Text] [Related]
38. Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.
Kim S; Zuiani A; Carrero JA; Hansen TH
Vaccine; 2012 Mar; 30(12):2178-86. PubMed ID: 22285270
[TBL] [Abstract][Full Text] [Related]
39. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
[TBL] [Abstract][Full Text] [Related]
40. Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways.
Rush C; Mitchell T; Garside P
J Immunol; 2002 Nov; 169(9):4951-60. PubMed ID: 12391208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]